New partnerships in real-time genomics promise faster, more accurate diagnoses for pediatric rare diseases.
New partnerships in real-time genomics promise faster, more accurate diagnoses for pediatric rare diseases.
A promising vaccine candidate advances efforts to combat neglected tropical diseases with mRNA innovation.
Partnership targets Alzheimer’s and Parkinson’s with novel delivery platforms and precision medicine approaches.
A pivotal step forward for Duchenne families as gene therapy shows promise to transform neuromuscular care.
A historic breakthrough as the first CRISPR-based gene-editing therapy gains FDA approval, offering new hope for sickle cell …
Already a subscriber? Log in